Home » Psychology news » Naurex’s Novel Antidepressant GLYX-13 Recognized As One Of Windhover’s Top 10 Neuroscience Projects To Watch

Naurex’s Novel Antidepressant GLYX-13 Recognized As One Of Windhover’s Top 10 Neuroscience Projects To Watch

September 1, 2010 by

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>